Every year a check arrives, or a credit posts, and someone in your finance meeting says the word “rebates” with relief. It is a real number. It is usually a large number. And it is very often the least useful number in your entire pharmacy program.
Here is the uncomfortable framing: a rebate is not a discount on what you paid. It is a partial refund of a price that was set higher partly so that a refund could exist. The size of the check tells you how the list price behaved. It tells you almost nothing about whether your plan’s actual net drug spend is good.
That distinction is the whole post. If you only take one thing: stop grading your pharmacy program on rebate dollars and start grading it on net cost per member per month. One of those numbers can be inflated to your disadvantage. The other cannot.
This is the same shape of problem we work through in Exposing the Hidden Costs of Health Insurance Broker Commissions: a headline number that looks like value while the actual economics sit one layer down.
What You’ll Learn
- What a pharmacy rebate actually is, and why it is not a discount.
- The three places rebate dollars disappear between the manufacturer and your plan.
- Why a bigger rebate check can mean a worse contract, not a better one.
- The four contract terms that decide whether rebates reach you.
- Six questions to ask your PBM, in writing, before you renew.
PBM Rebates Explained for Employers
Direct answer: A pharmacy rebate is a payment made by a drug manufacturer to a pharmacy benefit manager in exchange for a drug’s placement on the formulary. It is calculated off the drug’s list price, it is paid after the fact, and it flows to the PBM first. How much of it reaches your plan, and whether it reaches your members at the pharmacy counter, is determined entirely by your contract, not by the rebate itself.
Three features of that definition do the damage.
Rebates are keyed to list price, not to cost. A rebate is a percentage of a number the manufacturer sets. A higher list price with a bigger rebate can produce the same or worse net cost than a lower list price with no rebate at all, while generating a much more impressive-looking rebate report.
Rebates flow to the PBM first. They do not arrive at your plan and get shared with the PBM. They arrive at the PBM and get shared with you, in whatever proportion and on whatever definition your contract specifies. That direction of flow is the reason every one of the leaks below is possible.
Rebates are retrospective. They land months after the claims that generated them, which means the person deciding on formulary placement and the person feeling the cost are separated by both time and party. Your plan gets a partial refund later. Whether your members are also carrying part of the inflated price in the meantime depends on how your plan calculates cost-sharing, which is a question worth putting in writing, and one we come back to below.
If terms like formulary, spread, and rebate aggregator are doing heavy lifting here, the High Performance Benefits Glossary defines them in plain English.
BeneSmart Insight: A rebate is a refund on a price, not a reduction of it. Anything that can be inflated and refunded can be inflated more.
The Three Places Rebate Dollars Disappear
Direct answer: Rebate dollars disappear in three places between the manufacturer and your plan: in the definition of what counts as a rebate, in the retention taken before your share is calculated, and in the formulary decisions rebates quietly drive. Each is a contract problem, and each is invisible on a rebate report.
1. The definition
Your contract promises you a percentage of “rebates.” The decisive question is what that word covers.
Manufacturer money arrives under many names: rebates, administrative fees, data fees, service fees, grants, and payments to affiliated entities such as group purchasing organizations or rebate aggregators. A contract that guarantees you a high percentage of a narrowly defined term can pass through less real money than one guaranteeing a lower percentage of a broad one.
This is the single most common place value leaks, and it never appears as a leak. It appears as a definition, on a page nobody reads twice.
What to demand instead: a definition covering all manufacturer-derived revenue attributable to your plan’s utilization, regardless of what it is called or which affiliated entity receives it.
2. The retention
“100% pass-through” is a sentence with a load-bearing asterisk. Pass-through of what, calculated when, net of which deductions?
Watch for: rebates retained at an affiliated aggregator before the pass-through calculation begins; per-claim or per-script administrative fees netted out first; minimum guarantees structured so that anything above the guarantee is retained rather than shared; and exclusions for specific drug classes, frequently the specialty drugs where the dollars actually are.
What to demand instead: the pass-through percentage, the definition it applies to, and the deductions taken before it is applied. All three, in the same paragraph.
3. The formulary itself
This one is structural rather than contractual, and it is the most expensive of the three.
If a PBM’s economics improve when higher-list-price, higher-rebate drugs are preferred, then formulary design has a financial gradient built into it. That is not an accusation about any particular PBM; it is a description of how the incentive is shaped. A formulary that steers to a rebate-rich brand over a lower-net-cost alternative can increase your total spend while increasing your rebate check, and the rebate check is the number most employers grade on.
What to demand instead: the net cost per member per month, and a lowest-net-cost formulary option quoted alongside the standard one so you can see what you are trading.
BeneSmart Insight: All three leaks are invisible on a rebate report, because a rebate report only shows what arrived. The money you are looking for is defined out, netted out, or never generated in the first place.
Is your rebate check hiding your real pharmacy cost?
Grab the free Benefit Benchmarking Worksheet, the framework we use to put plan costs, including pharmacy net cost per member per month, into a comparison an employer can actually act on.
Download the free Benefit Benchmarking Worksheet
Why a Bigger Rebate Check Can Mean a Worse Deal
Direct answer: A larger rebate check can indicate a formulary weighted toward high-list-price drugs, which raises gross spend even when the refund grows. Because rebates are a percentage of list price, rebate volume and net cost can move in the same direction, which is why net cost per member per month is the only reliable scorecard.
Two plans, same drug, same clinical outcome. Plan A’s PBM prefers the high-list, high-rebate version. Plan B’s prefers the lowest-net-cost version.
Plan A’s rebate report looks dramatically better. Plan A’s gross spend runs against the higher list price all year. Plan A’s finance team celebrates a bigger check in the spring.
Which plan spent less? The rebate report cannot tell you, because it does not contain the answer. Only net cost can.
The illustration below is hypothetical and directional. It exists to show the mechanism, not to represent market pricing, a benchmark, or a client result. Do not cite these numbers.
| Illustrative comparison (hypothetical) | Plan A: rebate-optimized | Plan B: net-cost-optimized |
|---|---|---|
| Formulary preference | Higher-list, higher-rebate brand | Lowest-net-cost option |
| Rebate report headline | Large | Small |
| Gross spend basis | Higher list price | Lower list price |
| Number the plan is graded on | Rebate dollars | Net cost PMPM |
| Which number tells the truth | No | Yes |
Notice the row that matters is the last one, and notice that Plan A’s team is not doing anything foolish. They are optimizing the metric they were handed. The metric is the problem.
The pattern we see most often
A finance team brings us a rebate report they are pleased with. The report is accurate. It is also the only pharmacy number anyone in the room has ever been shown, which is the actual problem.
Read the contract behind it and one of the three leaks is almost always present, most often the definition, because it is the one that never looks like a leak. Then we ask for net cost per member per month, and it turns out nobody has ever produced that number, because nobody ever asked for it. The conversation changes at that moment, before a single contract term has been renegotiated.
This describes a recurring pattern across engagements, not a specific client, and contains no client figures.
BeneSmart Insight: Grade the program on net cost per member per month. A rebate number can be engineered upward. Net cost cannot.
The Four Contract Terms That Decide Everything
Direct answer: Four contract terms determine whether rebate value reaches your plan: the definition of manufacturer revenue, the pass-through percentage and its deductions, audit rights, and the formulary control you retain. Everything else in a PBM contract is downstream of these four.
- The revenue definition. Does it capture all manufacturer-derived revenue attributable to your utilization, under any label, through any affiliated entity? If it names only “rebates,” you have already lost the categories that are not called rebates.
- Pass-through, stated completely. The percentage, the base it applies to, and every deduction taken before the calculation. A percentage without the other two is a marketing number.
- Audit rights that are usable. Not just “the right to audit,” but: by an auditor of your choosing, against source documents, with defined scope, timing, and no penalty for exercising it. An audit right with a captive auditor and a narrow document scope is a formality. This is the same vetting discipline we apply to stop-loss carriers and TPAs in Traps in Stop-Loss Coverage.
- Formulary control. Can you require a lowest-net-cost option? Can you see the alternative that was not preferred, and what it would have cost? Without this, the other three terms govern the division of a pie whose size someone else is choosing.
What to Ask Your PBM, in Writing
Direct answer: Six written questions convert this from a concept into a negotiation: full manufacturer revenue disclosure, the complete pass-through calculation, net cost per member per month, a lowest-net-cost formulary quote, unrestricted audit terms, and confirmation of how member cost-sharing is calculated.
- “Disclose all revenue you or any affiliated entity receives that is attributable to our plan’s utilization, from any source, under any label.”
- “State the pass-through percentage, the exact definition it applies to, and every deduction taken before it is calculated.”
- “Report our net cost per member per month, by month, for the current and prior plan year.”
- “Quote a lowest-net-cost formulary alongside the standard formulary, and show the difference in net cost and in member cost-sharing.”
- “Provide audit rights with an auditor of our choosing, against source documents, with no restriction on scope or frequency.”
- “Confirm in writing whether member cost-sharing is calculated on list price or on net price.”
That last question is the one that changes the conversation from finance to people. If your plan calculates cost-sharing on list price, then every dollar of inflation that generates your rebate is also a dollar your employees are paying coinsurance against, at the counter, months before your plan sees any refund. If it calculates on net price, that is worth knowing too. Either way, the answer belongs in writing, and most employers have never asked for it.
You have more leverage here than the complexity suggests. Pharmacy is the most contractually determined piece of your benefits spend, which means it is also the most changeable, without touching a single benefit your employees actually use. And the sequencing matters more than the asks: for our clients, the pharmacy contract review sits at a specific point in a defined process, precisely because asking these six questions in the wrong order gets you six polished non-answers.
Frequently Asked Questions
What is a PBM rebate?
A PBM rebate is a payment from a drug manufacturer to a pharmacy benefit manager in exchange for a drug’s placement on the formulary. It is calculated as a percentage of the drug’s list price, paid retrospectively, and it flows to the PBM first. How much reaches the employer’s plan depends entirely on the PBM contract.
Are pharmacy rebates the same as a discount?
No. A discount reduces the price you pay at the point of sale. A rebate is a partial refund paid later on a list price that was set higher in part to accommodate it. Where a plan calculates member cost-sharing on list price, a rebate can arrive months after employees have already paid coinsurance on the inflated number, which is why it is worth confirming in writing which basis your plan uses.
Does 100% pass-through mean we get all the rebate money?
Not necessarily. Pass-through applies to whatever the contract defines as a rebate, after whatever deductions the contract allows. Manufacturer money labeled as administrative, data, or service fees, or routed through an affiliated aggregator, can fall outside that definition entirely while the pass-through percentage remains technically accurate.
Why would a bigger rebate check be a bad sign?
Because rebates are a percentage of list price, a large rebate can indicate a formulary weighted toward high-list-price drugs. That raises gross spend at the same time it raises the refund, so total net cost can worsen while the rebate report improves.
What should employers measure instead of rebates?
Net cost per member per month, tracked over time and compared against a lowest-net-cost formulary quote for the same population. Net cost captures the outcome that rebate reporting obscures, and it cannot be inflated by raising list prices.
About the Author
Rich Westermayer, Founder, BeneSmart. Rich entered the benefits industry in 2013 and spent nine years working the carrier side of the business before going fully independent. He launched his own firm in 2017 and has led BeneSmart since 2022 as an independent, flat-fee alternative to commission-driven benefits brokerage for 50 to 1,000 life employers, and he personally leads every Cost Containment Blueprint engagement. Direct line: 314-798-7563.
Find out what your pharmacy program actually costs, not what your rebate check says.
In a free Find Your Fit call, we will read your PBM contract against the four terms above and tell you, in plain English, which of the three leaks it contains.
What you get: a read on your revenue definition and pass-through language; the six written questions, ready to send; a net-cost-per-member-per-month framing you can take to your finance team; and where your audit rights fall short of usable.
No cost, no obligation, and you do not have to switch brokers to find out. We take a limited number of Blueprint clients each quarter.
Book My Free Find Your Fit Call · Or see what actually happens inside the Cost Containment Blueprint, or download the free Benefit Benchmarking Worksheet.
BeneSmart · www.benesmartservices.com · info@benesmartservices.com · 314-798-7563 · Schedule: https://calendly.com/benesmart/consult_teams